Christine Blank
FDA okays biosimilar for several cancers
While FDA has approved a handful of biosimilar drugs, the agency just approved the first biosimilar that treats a variety of types of cancer.
FDA warns Pfizer’s Meridian over EpiPen flaws
FDA warned about an injunction or seizure if Meridian Medical Technologies, a division of Pfizer, does not correct its problems with the EpiPen (epinephrine auto-injector).
FDA warns about deaths in cancer drug trials
An increased risk of deaths for patients in clinical trials receiving this cancer drug and two other drugs led FDA to stop the clinical trials.
Blockbuster diabetes drug earns heart indication
A top-selling diabetes drug has gained a cardiovascular indication from FDA.
Will new biosimilars hurt blockbuster autoimmune drug?
New biosimilars may harm the sales of this autoimmune blockbuster.
FDA okays targeted leukemia treatment
FDA approved a targeted new drug to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
FDA eyes opioids in kids' medicines
An FDA committee will review prescription opioid products containing hydrocodone or codeine to treat coughs in children.
Groups praise lawsuit against Walgreens, CVS
Pharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
FDA warns about contaminated drugs, dietary supplements
FDA warned consumers and health care professionals not to use a certain brand of drugs and dietary supplements that are contaminated.
DEA wants to slash opioid production
The Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.


View Results